Nivolumab + cabozantinib (NIVO+CABO) versus sunitinib (SUN) for advanced renal cell carcinoma (aRCC): Outcomes by sarcomatoid histology and updated trial results with extended follow-up of CheckMate 9ER - Motzer, RJ; Choueiri, TK; Powles, T (Journal of Clinical Oncology, 2021)
et al.